Tony Listro interviewed in Drug Development & Delivery

Don’t miss the interview with our Vice President of Technology and Site Lead for SPS’s North American site, Tony Listro, in the September issue of Drug Development & Delivery. Among other things, he explains why Sever Pharma Solutions emphasizes our ability to handle HPAPIs in polymer-based dosage forms and how he sees the polymers market and the CDMO segment shaping up in 2023.

Drug Development & Delivery, including its exclusive Specialty Pharma section, is a print publication, conference organizer (Drug Development Networking Summit), and online content provider exclusively committed to advancing the applied science, technology, and related business practices of pharmaceutical and biological drug development.

Read the whole article here.